|
Characteristic
|
Laparoscopic group
|
Open surgery group (control)
|
P value
|
|---|
|
Sex (cases)
| | |
0.904
|
|
Men
|
26
|
27
| |
|
Women
|
5
|
6
| |
|
Age (years)
| | |
0.413
|
|
Median
|
54
|
59.5
| |
|
Range
|
37–66
|
34–65
| |
|
BMI
| | |
0.912
|
|
Median
|
24.4
|
25.0
| |
|
Range
|
19.1–31.0
|
21.8–29.9
| |
|
Initial surgical lesion site (cases)
| | |
0.665
|
|
Right lobe
|
22
|
25
| |
|
Left lobe
|
9
|
8
| |
|
Primary tumor size (cm)
|
4.1 ± 1.5
|
4.9 ± 2.6
|
0.382
|
|
Time to recurrence (months)
|
28.4 ± 27.7
|
27.5 ± 16.3
|
0.282
|
|
Size of recurrent tumor (cm)
|
2.5 ± 1.0
|
3.8 ± 1.1
|
0.45
|
|
Recurrent site (cases)
| | |
0.632
|
|
Right lobe
|
16
|
19
| |
|
Left lobe
|
15
|
14
| |
|
Operation method (cases)
| | |
0.955
|
|
Left lateral lobectomy
|
12
|
13
| |
|
Local resection
|
19
|
20
| |
|
Total bilirubin (μmol/L)
|
31.2 ± 7.4
|
33.7 ± 10.4
|
0.742
|
|
Albumin (g/L)
|
35.2 ± 3.3
|
36.4 ± 4.3
|
0.532
|
|
ALT (U/L)
|
49.6 ± 6.4
|
76.3 ± 7.5
|
0.671
|
|
AST (U/L)
|
52.4 ± 7.4
|
69.4 ± 8.4
|
0.832
|
|
Prothrombin time (s)
|
11.5 ± 0.7
|
12.4 ± 1.0
|
0.651
|
|
AFP (cases)
| | |
0.264
|
|
>400 ng/mL
|
27
|
24
| |
|
<400 ng/mL
|
4
|
9
| |
|
HBV-DNA (log10 IU/mL)
|
3.50 ± 0.8
|
3.0 ± 0.2
|
0.192
|
-
BMI body mass index, ALT alanine aminotransferase, AST aspartate aminotransferase, AFP α-fetoprotein, HBV hepatitis B virus
